BABaxter International BAX · NYSE
$22.98 -2.21% (-$0.52)
- Market cap
- $12.1B
- Enterprise value
- $19.7B
- P/E
- -
- Forward P/E
- 11.5x
- PEG
- -
- P/S
- 1.1x
- P/FCF
- 17.9x
- EV/EBITDA
- 26.2x
- ROIC
- -3.2%
- Gross margin
- 30.1%
- Net margin
- -9.3%
- Dividend yield
- 0.17%
- Payout ratio
- -
- Net debt/EBITDA
- 10.0x
- Beta
- 0.65
- Free float
- 99.4%
About the company
Baxter International Inc. (BAX) is an American healthcare company specializing in the development, manufacture, and distribution of medical devices, pharmaceutical products, and biological therapies. With a broad portfolio of products focused on the care of patients with hemophilia, kidney diseases, immune disorders, and other serious health conditions, Baxter is one of the leading players in the healthcare industry. The company is known for its emphasis on innovation and quality, enabling it to provide top-notch solutions to improve the health and quality of life of patients. Baxter International also invests in research and development of new treatment methods and technologies. Baxter International Inc. (BAX) shares could be suitable for investors looking for opportunities in the healthcare sector with a focus on innovation and a broad therapeutic portfolio.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Andrew Hider
Employees
37,500
Headquarters
Deerfield
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: Repaying its net debt would take 10.0 years of operating profit.
Capital and dividends
What does the company do with the money it earns?
- What to watch: It cut its dividend by 50% last year.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
- What speaks for it: The price moves less than the market (beta 0.65).
Statements
Every number